Results 31 to 40 of about 2,143 (149)

Current Knowledge in Allergic Conjunctivitis

open access: yesTürk Oftalmoloji Dergisi, 2021
Allergic conjunctivitis is a disease of increasing prevalence that affects both children and adults and causes significant deterioration of their quality of life and sometimes irreversible visual damage.
Beatriz Vidal Villegas   +1 more
doaj   +1 more source

Treatment of Corneal Lesions in Individuals with Vernal Keratoconjunctivitis

open access: yesAllergology International, 2005
Vernal keratoconjunctivitis, a severe form of allergic conjunctival disease, is characterized by the development of various types of corneal lesions in conjunction with proliferative changes in the conjunctiva. Expression of bioactive substances, such as
Naoki Kumagai   +4 more
doaj   +1 more source

Shield ulcer: A very rare presentation

open access: yesKerala Journal of Ophthalmology, 2017
Shield ulcer is a severe form of vernal keratoconjunctivitis (VKC). Shield ulcer is an uncommon, incapacitating corneal manifestation that occurs in 3%–11% of patients suffering from VKC. Patients might present with intense itching, sensitivity to light,
Sujit Das
doaj   +1 more source

An unusual presentation of vernal keratoconjunctivitis

open access: yesIndian Journal of Ophthalmology. Case Reports, 2023
Vernal keratoconjunctivitis is diagnosed mainly on the basis of typical signs and symptoms of allergic conjunctivitis such as conjunctival papillae, limbal gelatinous thickening, peri-limbal Horner–Trantas dots, and shield ulcers.
Bijnya B Panda   +2 more
doaj   +1 more source

Understanding vernal keratoconjunctivitis in children

open access: yesAfrican Vision and Eye Health, 2020
Background: Vernal keratoconjunctivitis (VKC) is a public health problem that mostly affects children in warm subtropical climates. Unfortunately, the causative factors of the disease are not clearly defined, thus posing a serious management challenge to
Hlupheka L. Sithole
doaj   +1 more source

Long-term efficacy of omalizumab in patients with conventional treatment-resistant vernal keratoconjunctivitis

open access: yesRevista Alergia México, 2018
Background: In vernal keratoconjunctivitis, traditional treatments are sometimes insufficient for symptom control; the results with omalizumab are promising in resistant cases.
Luis Santamaria, Jorge Sánchez
doaj   +1 more source

Clinical presentation of vernal keratoconjunctivitis in Bharatpur Medical College

open access: yesJournal of College of Medical Sciences-Nepal, 2015
Background & Objectives: To evaluate the different clinical presentation of Vernal Keratoconjunctivitis (VKC) in our context.Materials & Methods: Ninety diagnosed VKC patients attending the outpatient department of College of Medical Sciences ...
Polina Dahal, Sanjeet Bhattarai
doaj   +1 more source

Clinicodemographic profile of VKC patients in tertiary care centre of North India: A prospective study

open access: yesTNOA Journal of Ophthalmic Science and Research
Objective: To know the demography and clinical profile of patients of vernal keratoconjunctivitis (VKC) in a tertiary care center over a period of 6 months from April 2023 to September 2023.
Manpreet Kaur   +2 more
doaj   +1 more source

A STUDY TO EVALUATE AND COMPARE THE EFFICACY AND SAFETY OF TOPICAL CYCLOSPORINE-A 0.5% WITH TOPICAL PLACEBO (ARTIFICIAL TEARS) IN ALLEVIATING THE CLINICAL FEATURES ASSOCIATED WITH VERNAL KERATOCONJUNCTIVITIS

open access: yesNational Journal of Medical Research, 2016
Introduction: Vernal keratoconjunctivitis is a severe, typically seasonal recurrent ocular inflammatory disorder. Topical cyclosporine-A is inhibitory to many T-cell dependent inflammatory mechanisms which are likely to play role in treatment of vernal ...
Abha Gahlot   +4 more
doaj  

Rebamipide 2% Ophthalmic Suspension for the Treatment of Allergic Keratoconjunctivitis: A Hospital Based Study

open access: yesDelhi Journal of Ophthalmology, 2016
Background: The aim of this study was to evaluate the effectiveness of Rebamipide 2% ophthalmic suspension in the treatment of Allergic Keratoconjunctivitis.
Munish Dhawan, Tania Hans, Baltej Singh
doaj   +1 more source

Home - About - Disclaimer - Privacy